Antiphospholipid syndrome and pregnancy
- 作者: Gris J.1,2,3, Makatsariya A.D3, Bitsadze V.O3, Khizroeva D.K.3, Khamani N.M3
-
隶属关系:
- University hospital, Nîmes
- University of Montpellier
- I.M. Sechenov First Moscow State Medical University
- 期: 编号 10 (2018)
- 页面: 5-11
- 栏目: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248253
- DOI: https://doi.org/10.18565/aig.2018.10.5-11
- ID: 248253
如何引用文章
详细
全文:
作者简介
Jean-Christophe Gris
University hospital, Nîmes; University of Montpellier; I.M. Sechenov First Moscow State Medical UniversityM.D., Ph.D., Professor of Department of Haematology; Professor of Obstetrics and Gynecology, Department of obstetrics and gynecology #2
A. Makatsariya
I.M. Sechenov First Moscow State Medical University
Email: gemostasis@mail.ru
M.D, PhD, corresponding member of the Russian Academy of Sciences, Professor, Head of the Department of obstetrics and gynecology #2
V. Bitsadze
I.M. Sechenov First Moscow State Medical University
Email: vikabits@mail.ru
MD, Professor of the Russian Academy of Sciences, Professor of the Department of obstetrics and gynecology #2
D. Khizroeva
I.M. Sechenov First Moscow State Medical University
Email: jamatotu@gmail.com
MD, Professor of the Department of obstetrics and gynecology #2
N. Khamani
I.M. Sechenov First Moscow State Medical University
Email: nadinka@list.ru
postgraduate student of the Department of Obstetrics and Gynecology #2
参考
- Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 2006; 4(2): 295-306.
- Arnout J. The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin-induced thrombocytopenia. Thromb. Haemost. 1996; 75(4): 536-41.
- Hughes G.R. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br. Med. J. (Clin. Res. Ed). 1983; 287(6399): 1088-9.
- de Groot P.G., Meijers J.C. β(2)-Glycoprotein I: evolution, structure and function. J. Thromb. Haemost. 2011; 9(7): 1275-84.
- de Laat B., Pengo V., Pabinger I., Musial J., Voskuyl A.E., Bultink I.E. et al. The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. J. Thromb. Haemost. 2009; 7(11): 1767-73.
- Hoxha A., Mattia E., Tonello M., Grava C., Pengo V, Ruffatti A. Antiphosphatidylserine/prothrombin antibodies as biomarkers to identify severe primary antiphospholipid syndrome. Clin. Chem. Lab. Med. 2017; 55(6): 890-8.
- Mekinian A., Bourrienne M.C., Carbillon L., Benbara A., Noémie A., Chollet-Martin S. et al. Non-conventional antiphospholipid antibodies in patients with clinical obstetrical APS: Prevalence and treatment efficacy in pregnancies. Semin. Arthritis Rheum. 2016; 46(2): 232-7.
- Poindron V., Berat R., Knapp A.M., Toti F., Zobairi F., Korganow A.S. et al. Evidence for heterogeneity of the obstetric antiphospholipid syndrome: thrombosis can be critical for antiphospholipid-induced pregnancy loss. J. Thromb. Haemost. 2011; 9(10): 1937-47.
- Gris J.C., Bouvier S., Molinari N., Galanaud J.P., Cochery-Nouvellon E., Mercier E. et al. Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study. Blood. 2012; 119(11): 2624-32.
- Bates S.M., Greer I.A., Middeldorp S., Veenstra D.L., Prabulos A.M., Vandvik P.O. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2, Suppl.): e691S-736S.
- Akinshina S., Makatsariya A., Bitsadze V., Khizroeva О., Khamani N. Thromboprophylaxis in pregnant women with thrombophilia and a history of thrombosis. J. Perinat. Med. 2018; Jun 27. pii: /j/jpme.ahead-of-print/jpm-2017-0329/jpm-2017-0329.xml.
- Mekinian A., Alijotas-Reig J., Carrat F., Costedoat-Chalumeau N., Ruffatti A., Lazzaroni M.G. et al.; on the behalf of the SNFMI and the European Forum on Antiphospholipid Antibodies. Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study. Autoimmun. Rev. 2017; 16(7): 730-4.
- Branch D.W., Peaceman A.M., Druzin M., Silver R.K., El-Sayed Y., Silver R.M. et al. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am. J. Obstet. Gynecol. 2000; 182(1, Pt 1): 122-7.
- Mekinian A., Lazzaroni M.G., Kuzenko A., Alijotas-Reig J., Ruffatti A., Levy P. et al.; SNFMI and the European Forum on Antiphospholipid Antibodies. The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study. Autoimmun. Rev. 2015; 14(6): 498-502.
- Lefkou E., Mamopoulos A., Dagklis T., Vosnakis C., Rousso D., Girardi G. Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy. J. Clin. Invest. 2016; 126(8): 2933
- Khizroeva J., Bitsadze V., Makatsariya A. Catastrophic antiphospholipid syndrome and pregnancy. Clinical report. J. Matern. Fetal Neonatal Med. 2018; Jan 8